Establishment Labs Holdings Inc. (NASDAQ:ESTA) Short Interest Up 8.1% in March

Establishment Labs Holdings Inc. (NASDAQ:ESTA) saw a significant growth in short interest in March. As of March 31st, there was short interest totalling 4,930,000 shares, a growth of 8.1% from the March 15th total of 4,560,000 shares. Based on an average daily volume of 457,400 shares, the short-interest ratio is currently 10.8 days. Approximately 21.7% of the shares of the stock are short sold.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the business. Bank of New York Mellon Corp increased its stake in shares of Establishment Labs by 22.4% during the 1st quarter. Bank of New York Mellon Corp now owns 18,643 shares of the company’s stock worth $1,256,000 after purchasing an additional 3,416 shares during the last quarter. Bank of Montreal Can bought a new stake in shares of Establishment Labs during the 1st quarter worth about $1,408,000. BlackRock Inc. boosted its holdings in shares of Establishment Labs by 2.5% during the 1st quarter. BlackRock Inc. now owns 90,995 shares of the company’s stock worth $6,133,000 after buying an additional 2,198 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Establishment Labs by 4.3% during the 1st quarter. Vanguard Group Inc. now owns 75,747 shares of the company’s stock worth $5,104,000 after buying an additional 3,154 shares during the period. Finally, Affinity Asset Advisors LLC boosted its holdings in shares of Establishment Labs by 125.2% during the 1st quarter. Affinity Asset Advisors LLC now owns 174,500 shares of the company’s stock worth $11,760,000 after buying an additional 97,000 shares during the period. Institutional investors own 72.91% of the company’s stock.

Establishment Labs Trading Up 0.8 %

NASDAQ ESTA traded up $0.41 during trading hours on Wednesday, hitting $52.15. The company’s stock had a trading volume of 202,493 shares, compared to its average volume of 435,848. The stock has a fifty day moving average of $46.09 and a 200 day moving average of $36.07. Establishment Labs has a twelve month low of $16.96 and a twelve month high of $77.55. The firm has a market capitalization of $1.43 billion, a P/E ratio of -17.15 and a beta of 1.24. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 10.26.

Establishment Labs (NASDAQ:ESTA) last posted its earnings results on Wednesday, February 28th. The company reported ($0.79) earnings per share for the quarter, topping the consensus estimate of ($0.95) by $0.16. The company had revenue of $31.60 million for the quarter, compared to analyst estimates of $31.44 million. Establishment Labs had a negative net margin of 47.53% and a negative return on equity of 357.81%. The business’s revenue for the quarter was down 27.9% compared to the same quarter last year. During the same period last year, the business posted ($0.55) earnings per share. Equities research analysts forecast that Establishment Labs will post -1.58 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Citigroup upped their target price on shares of Establishment Labs from $49.00 to $60.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Mizuho upped their target price on shares of Establishment Labs from $50.00 to $65.00 and gave the stock a “buy” rating in a research report on Monday, April 1st. JPMorgan Chase & Co. increased their price objective on shares of Establishment Labs from $46.00 to $53.00 and gave the company an “overweight” rating in a report on Thursday, February 29th. Finally, Stephens restated an “overweight” rating and issued a $47.00 price objective on shares of Establishment Labs in a report on Thursday, January 11th. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $63.33.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.